Biodegradable nanoplatforms for antigen delivery: part I - state of the art review of polymeric nanoparticles for cancer immunotherapy.

Expert opinion on drug delivery Pub Date : 2024-08-01 Epub Date: 2024-09-08 DOI:10.1080/17425247.2024.2400293
Estefanía Vega, Jordi Madariaga Burgos, Eliana B Souto, María Luisa García, Montserrat Pujol, Elena Sánchez-López
{"title":"Biodegradable nanoplatforms for antigen delivery: part I - state of the art review of polymeric nanoparticles for cancer immunotherapy.","authors":"Estefanía Vega, Jordi Madariaga Burgos, Eliana B Souto, María Luisa García, Montserrat Pujol, Elena Sánchez-López","doi":"10.1080/17425247.2024.2400293","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Polymeric nanoparticles used for antigen delivery against infections and for cancer immunotherapy are an emerging therapeutic strategy in promoting the development of innovative vaccines. Beyond their capability to create targeted delivery systems with controlled release of payloads, biodegradable polymers are utilized for their ability to enhance the immunogenicity and stability of antigens.</p><p><strong>Areas covered: </strong>This review extensively discusses the physicochemical parameters that affect the behavior of nanoparticles as antigen-delivery systems. Additionally, various types of natural and synthetic polymers and recent advancements in nanoparticle-based targeted vaccine production are reviewed.</p><p><strong>Expert opinion: </strong>Biodegradable polymeric nanoparticles have gained major interest in the vaccination filed and have been extensively used to encapsulate antigens against a wide variety of tumors. Moreover, their versatility in terms of tunning their physicochemical characteristics, and their surface, facilitates the targeting to antigen presenting cells and enhances immune response.</p>","PeriodicalId":94004,"journal":{"name":"Expert opinion on drug delivery","volume":" ","pages":"1251-1262"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert opinion on drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17425247.2024.2400293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Polymeric nanoparticles used for antigen delivery against infections and for cancer immunotherapy are an emerging therapeutic strategy in promoting the development of innovative vaccines. Beyond their capability to create targeted delivery systems with controlled release of payloads, biodegradable polymers are utilized for their ability to enhance the immunogenicity and stability of antigens.

Areas covered: This review extensively discusses the physicochemical parameters that affect the behavior of nanoparticles as antigen-delivery systems. Additionally, various types of natural and synthetic polymers and recent advancements in nanoparticle-based targeted vaccine production are reviewed.

Expert opinion: Biodegradable polymeric nanoparticles have gained major interest in the vaccination filed and have been extensively used to encapsulate antigens against a wide variety of tumors. Moreover, their versatility in terms of tunning their physicochemical characteristics, and their surface, facilitates the targeting to antigen presenting cells and enhances immune response.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于抗原递送的生物可降解纳米平台:第一部分--用于癌症免疫疗法的聚合物纳米颗粒的最新进展回顾。
导言:用于抗感染和癌症免疫疗法的聚合物纳米颗粒是促进创新疫苗开发的一种新兴治疗策略。可生物降解的聚合物不仅能创建靶向递送系统,控制有效载荷的释放,还能增强抗原的免疫原性和稳定性:本综述广泛讨论了影响纳米颗粒作为抗原递送系统行为的物理化学参数。此外,还综述了各种类型的天然和合成聚合物以及基于纳米粒子的靶向疫苗生产的最新进展:可生物降解的聚合物纳米粒子在疫苗接种领域已获得了极大的关注,并已被广泛用于封装抗原以预防多种肿瘤。此外,可降解聚合物纳米颗粒在调整其理化特性和表面方面具有多功能性,有助于靶向抗原呈递细胞并增强免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
An opinion on advanced cancer immunotherapy through innovations in PD-1 inhibitor delivery systems. Acceptability of Cyltezo pen among biologics autoinjector patients, autoinjector naïve patients, and healthcare professionals. The potential of nanosystems in disrupting adenosine signaling pathways for tumor immunotherapy. How can nanoemulsions be used for photosensitizer drug delivery? Advanced drug delivery strategies for diabetic retinopathy: a comprehensive review on current medications, delivery methods, device innovations, overcoming barriers, and experimental models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1